Share this article
Share this article
ROCKVILLE, Md., Feb. 18, 2021 /PRNewswire/ The National Foundation for Cancer Research (NFCR) announced today that the 2021 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Tak W. Mak, Ph.D., senior scientist at the Princess Margaret Cancer Centre and university professor at the University of Toronto, and Mark M. Davis, Ph.D., professor of microbiology and immunology at the Stanford University School of Medicine, for their breakthrough discoveries of the structure of T-cell receptor (TCR) and pioneering research in deciphering the mechanisms of T-cell recognition and development. These discoveries have formed a critical part of contemporary immuno-oncology and the molecular foundation for life-saving CAR (chimeric antigen receptor) T-cell therapies, a novel T-cell-based immunotherapy approach already approved by the U.S. Food and Drug Administration (FDA) for the treatment of several types of blood cancer.
Bhavesh V. (Bob) Patel has joined Halliburton s board of directors.
Halliburton Co. (NYSE: HAL) reported Wednesday that Bhavesh V. (Bob) Patel has joined the service company’s board of directors.
The appointment of Patel, the CEO of LyondellBasell (NYSE: LYB), is effective Feb. 17, 2021, and he will stand for election by HAL stockholders at the company’s May 19, 2021, annual meeting, Halliburton noted in a written statement.
“Bob has a distinguished track record in safety and operational excellence,” remarked Jeff Miller, Halliburton’s chairman, president, and CEO. “This experience, along with his vast global leadership, will provide great value to Halliburton as we build our strong international business.”
ASCO GU 2021: Enfortumab Vedotin in Previously Treated Urothelial Cancer - Results of EV-301 & EV-201 Cohort 2 Discussion
Published 17 February 2021
(UroToday.com) In this presentation, Arlene O. Siefker-Radtke, MD from the University of Texas MD Anderson Cancer Center provided a discussion on two presentations on Enfortumab Vedotin (EV) in previously treated urothelial cancer. She first reviewed the results of EV-301 (Abstract 393) which provided level 1 evidence of overall survival benefit with EV compared to single-agent chemotherapy in patients who progressed on platinum chemotherapy and immune checkpoint blockade. The trial schema and relevant overall survival data are re-shown below. EV also demonstrated a progression-free survival benefit and improved overall response rates to 41% from 18% with single-agent chemotherapy.
Pharmacy Technician Certification Board (PTCB) Launches Immunization Credential for Pharmacy Technicians
Certificate demonstrates qualifications to administer COVID-19 vaccines
News provided by
Share this article
Share this article
WASHINGTON, Feb. 17, 2021 /PRNewswire/ As more pharmacies deliver COVID-19 vaccines across the US, the Pharmacy Technician Certification Board (PTCB), the nation s leading credentialing organization for pharmacy technicians, launches its new Assessment-Based Certificate in Immunization Administration, and is accepting applications now. The credential demonstrates a Certified Pharmacy Technician s (CPhT s) qualification to safely deliver immunizations and manage related tasks, including preparation, documentation, storage, and disposal. Pharmacy technicians are a critical component of the health care workforce that is administering and managing COVID-19 vaccines, said PTCB Executive Director and CEO William Schimmel. PTCB s Immunization Administ
Share this article
Share this article
WOODLANDS, Texas, Feb. 16, 2021 /PRNewswire/ Asit J. Choksi, MD, FACP, is being recognized by Continental Who s Who as a Leading Oncologist for his outstanding contributions in the field of Medicine and in acknowledgment for his pursuit for excellence with Texienne Oncology Centers and Texienne Physicians Medical Association, PLLC.
(PRNewsfoto/Continental Who s Who)
At Texienne Oncology Centers and Texienne Physicians Medical Association, Dr. Choksi and his highly qualified staff are committed to his vision of providing quality patient care to the surrounding communities of Woodlands, Texas. For over 25 years, together they continue to demonstrate integrity and focus on the patient s diagnosis for more personalized treatments. By tending to the emotional needs of cancer patients and their families, Dr. Choksi possesses the innate ability to go above and beyond traditional boundaries for more comprehensive tre